Verastem, Inc.
Clinical trials sponsored by Verastem, Inc., explained in plain language.
-
New hope for japanese women with rare ovarian cancer: drug combo shows promise
Disease control OngoingThis study tests two drugs, avutometinib and defactinib, in 16 Japanese patients whose low-grade serous ovarian cancer has returned after platinum-based chemotherapy. The goal is to see if the combination can shrink or control the cancer. Participants must have measurable disease…
Phase: PHASE2 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated May 26, 2026 11:19 UTC
-
New hope for pancreatic cancer: drug cocktail shows promise in early trial
Disease control OngoingThis study tests a combination of four drugs—two standard chemotherapy drugs plus two experimental ones—in people with advanced pancreatic cancer that has spread. The goal is to see if this mix is safe and can shrink tumors. About 40 adults who haven't had treatment yet will take…
Phase: PHASE1, PHASE2 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated May 22, 2026 14:05 UTC